Noor Ul Ain Rehman
Thu, April 2, 2026 astatine 9:46 AM CDT 1 min read
For further perspective, successful its fiscal Q4 and afloat twelvemonth 2025 results, Amgen Inc. (NASDAQ:AMGN) reported beardown show successful the afloat twelvemonth with double-digit maturation successful revenues and EPS. Total revenues for fiscal Q4 roseate 9% to $9.9 cardinal compared to the anterior twelvemonth period, with merchandise income increasing 7%, driven by 10% measurement growth. Total revenues for the afloat twelvemonth reached $36.8 billion, up 10% compared to the aforesaid 4th past year.
Amgen Inc. (NASDAQ:AMGN) is simply a biotechnology institution that discovers, develops, manufactures, and markets quality therapeutics. It delivers caller therapies for patients with analyzable cancers, particularly successful areas with important unmet needs.
While we admit the imaginable of AMGN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich successful 10 Years AND 12 Best Stocks That Will Always Grow.
Disclosure: None. Follow Insider Monkey connected Google News.

2 hours ago
1





English (CA) ·
English (US) ·
Spanish (MX) ·